ID
45877
Descripción
Principal Investigator: Steven A. Rosenberg, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA MeSH: Colonic Neoplasms,Ovarian Neoplasms,Stomach Neoplasms,Cholangiocarcinoma,Pancreatic Neoplasms,Rectal Neoplasms,Esophageal Neoplasms,Colorectal Neoplasms,Endometrial Neoplasms,Paraneoplastic Syndromes, Ocular https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs001003 Recent advances and insights into the molecular pathogenesis of cancer have led to the development of novel molecular and biologic targeted therapies for the treatment of advanced cancer patients. A critical challenge in extending these studies involves the identification and validation of new therapeutic targets for future cancer therapies. In this study, we performed whole exome and RNA-Seq analysis metastases to determine the nature and frequency of somatic mutations.
Link
Palabras clave
Versiones (1)
- 6/11/23 6/11/23 - Simon Heim
Titular de derechos de autor
Steven A. Rosenberg, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
Subido en
6 de noviembre de 2023
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY 4.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
dbGaP phs001003 Prospective Procurement of Solid Tumor Tissue to Identify Novel Therapeutic Targets
Eligibility Criteria
- StudyEvent: SEV1
- Eligibility Criteria
- The subject consent file includes subject IDs and consent information.
- This data table contains a mapping of study subject IDs to sample IDs. Samples are the final preps submitted for genotyping, sequencing, and/or expression data. For example, if one patient (subject ID) gave one sample, and that sample was processed differently to generate 2 sequencing runs, there would be two rows, both using the same subject ID, but having 2 unique sample IDs.
- This subject phenotype table contains subject IDs, cancer histology, age, and gender.
- This data table contains a mapping of samples IDs and SRA accession IDs.
- This sample attributes table contains sample IDs, histological type, analyte type, body site where sample was collected, and tumor status.
Similar models
Eligibility Criteria
- StudyEvent: SEV1
- Eligibility Criteria
- The subject consent file includes subject IDs and consent information.
- This data table contains a mapping of study subject IDs to sample IDs. Samples are the final preps submitted for genotyping, sequencing, and/or expression data. For example, if one patient (subject ID) gave one sample, and that sample was processed differently to generate 2 sequencing runs, there would be two rows, both using the same subject ID, but having 2 unique sample IDs.
- This subject phenotype table contains subject IDs, cancer histology, age, and gender.
- This data table contains a mapping of samples IDs and SRA accession IDs.
- This sample attributes table contains sample IDs, histological type, analyte type, body site where sample was collected, and tumor status.
C0680251 (UMLS CUI [1,2])
C0439091 (UMLS CUI [1,2])
C0280100 (UMLS CUI [1,2])
C0677930 (UMLS CUI [1,3])
C0027627 (UMLS CUI [1,4])
C0183882 (UMLS CUI [1,5])
C0430027 (UMLS CUI [1,6])
C1522593 (UMLS CUI [1,7])
C0543467 (UMLS CUI [1,8])
C0005558 (UMLS CUI [1,9])
C2936643 (UMLS CUI [1,10])
C1522577 (UMLS CUI [1,11])
C0031809 (UMLS CUI [1,2])
C5445108 (UMLS CUI [1,3])
C4047968 (UMLS CUI [1,4])
C3244099 (UMLS CUI [1,5])
C0162791 (UMLS CUI [1,6])
C0332152 (UMLS CUI [1,7])
C0005558 (UMLS CUI [1,8])
C0543467 (UMLS CUI [1,9])
C0580737 (UMLS CUI [1,2])
C0023416 (UMLS CUI [1,2])
C1512693 (UMLS CUI [1,3])
C0521144 (UMLS CUI [1,2])
C0853904 (UMLS CUI [1,2])
C0442816 (UMLS CUI [1,2])
Sin comentarios